National and Kapodistrian University of Athens
Νέες τεχνολογίες μοριακών γενετικών αναλύσεων στη διάγνωση και στην πρόγνωση του καρκίνου με έμφαση στο μαστό και στο παχύ έντερο
Abstract
dc:descriptionBreast cancer is the second most common type of cancer in the female population, while ovarian cancer ranks sixth. The disease is inherited in an autosomal dominant manner. BRCA1 & BRCA2 gene mutations account for 5-10% of clinical cases of breast and/or ovarian cancer. With the evaluation made regarding the mutations in the Greek population and the detection of pathogenic mutations in genes other than BRCA1 and BRCA2 we conclude that the mutation gene panel examination is very important. the most useful tool for the detection of as many mutations as possible, but also for the detection of large deletions or duplications, is WGS, where the analysis of CNVs can also be carried out. This additional information may help in the early diagnosis of breast cancer and subsequently in its better prognosis. The aim of the present study , regarding breast cancer, was to evaluate the techniques and their results so as to use the most suitable ones for immediate diagnosis and better prognosis. In the colon, the change in the methylation pattern is observed in the early stages of cancer and is directly linked to the onset of the disease. Early detection of polyps reduces the risk of metastases through their subsequent removal, while the diagnosis of colon cancer at an early asymptomatic stage ensures a greater chance of successful treatment. Early detection of polyps reduces the risk of metastases through their subsequent removal, while the diagnosis of colon cancer at an early asymptomatic stage ensures a greater chance of successful treatment. Therefore, it was deemed necessary to develop a non-invasive screening method for suspicious cases. The method is based on the evaluation of the epigenetic marker of methylation in epithelial cells that have been excreted with the feces. Specifically, the methylation levels of three genomic regions of DNA extracted from epithelial cells are determined. Feces appear to be the sample of choice for non-invasive colon cancer screening as DNA (ctDNA) is derived directly from tumor tissue and/or precancerous lesions. The method was evaluated and it is very important that it seems to be able to detect even very small lesions (polyps). In conclusion, it is a method that can contribute to the early diagnosis and therefore to the good prognosis of colon cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzidaki, Maria
- Χατζηδάκη, Μαρία
Subjects
dc:subject × 24- Μοριακές τεχνικές
- Δίαγνωση καρκίνου
- Πρόγνωση καρκίνου
- Καρκίνος μαστού
- Καρκίνος παχέος εντέρου
- Molecular techniques
- Cancer diagnosis
- Cancer prognosis
- Breast cancer
- Colon cancer
- Βιολογία
- Φυσικές Επιστήμες
- Γενετική και Κληρονομικότητα
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική γενετική
- Ογκολογία
- Biological Sciences
- Natural Sciences
- Genetics and Heredity
- Clinical Medicine
- Medical and Health Sciences
- Clinical Genetics
- Oncology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54898